alanylglutamine has been researched along with Diabetic Angiopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deryagin, MN; Efremov, SM; Karaskov, AM; Lomivorotov, VN; Lomivorotov, VV; Ponomarev, DN; Shmirev, VA; Svyatchenko, AV | 1 |
1 trial(s) available for alanylglutamine and Diabetic Angiopathies
Article | Year |
---|---|
Does glutamine promote benefits for patients with diabetes mellitus scheduled for cardiac surgery?
Topics: Aged; Blood Glucose; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptides; Double-Blind Method; Fatty Acids; Female; Glutamine; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Triglycerides; Troponin I | 2013 |